EASI Score

San Francisco, USA | March 28, 2026 Phase 2b Data Demonstrates Strong Clinical Efficacy Nektar Therapeutics has announced compelling...

PALO ALTO, Calif. & NEW YORK, Feb. 10, 2026 — Clinical-stage biotechnology company Evommune announced positive top-line results from...